Skip to main content

NovoCure Ltd

NVCR
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001645113

No open-market purchases or sales by NovoCure Ltd insiders were filed in the last 90 days; 218 institutions reported holding it in 13F filings for Q2 2026, worth $1.57B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by NovoCure Ltd insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for NovoCure Ltd, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for NovoCure Ltd
NameTitleLast reported holdingLast filingFilings, past year
Puri Michal NathChief Human Resources Officer203,227Jul 1, 20264
Leonard Frank XChief Executive Officer461,425Jul 1, 20265
Ben Arye BarakGeneral Counsel243,752Jul 1, 20263
Danziger AsafDirector416,742Jul 1, 20261
Hilleman Jeryl LDirector25,471Jun 5, 20262
Leung GabrielDirector101,109Jun 5, 20262
Hung DavidDirector32,075Jun 5, 20262
Vernon W AnthonyDirector209,267Jun 5, 20263
Scannell Timothy JDirector25,898Jun 5, 20262
Madden Martin J.Director30,284Jun 5, 20261
Ocean Allyson JDirector22,934Jun 5, 20262
Stafford KristinDirector22,934Jun 5, 20262
Doyle William FExecutive Chairman328,397Mar 5, 20261
Weinberg UriChf Medical and Innovation Ofr267,190Mar 5, 20262
Cordova AshleyFormer Chief Executive Officer422,570Mar 5, 20262
Leupin NicolasFormer Chief Medical Officer102,979Mar 5, 20262
Paravasthu MukundChief Operating Officer72,832Mar 5, 20264
Brackmann ChristophChief Financial Officer182,842Mar 5, 20262
Groenhuysen Wilhelmus CMChief Operating Officer252,290Aug 6, 20240
Giladi MosheChief Science Officer69,771Feb 29, 20240
Shah PriteshChief Growth Officer124,511Nov 8, 20230
Burke William PatrickChief Human Resources Officer66,447Jul 6, 20230
Benaim ElyChief Medical Officer28,770Jan 10, 20230
Longsworth Todd ChristopherGeneral Counsel62,462Mar 9, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 5, 2026 (view filing)Jun 41 dayLeonard Frank XChief Executive OfficerSSale−34.3K$17.93−$614.5K−6.9%459.5K after
Jun 3, 2026 (view filing)Jun 21 dayStafford KristinDirectorSSale−2.94K$15.77−$46.4K−20.6%11.3K after
Jun 3, 2026 (view filing)Jun 21 dayOcean Allyson JDirectorSSale−2.94K$15.77−$46.4K−20.6%11.3K after
Jun 3, 2026 (view filing)Jun 21 dayScannell Timothy JDirectorSSale−2.94K$15.77−$46.4K−17.1%14.3K after
Jun 3, 2026 (view filing)Jun 21 dayVernon W AnthonyDirectorSSale−2.94K$15.77−$46.4K−1.5%197.7K after
Jun 3, 2026 (view filing)Jun 21 dayHung DavidDirectorSSale−2.94K$15.77−$46.4K−12.6%20.5K after
Jun 3, 2026 (view filing)Jun 21 dayLeung GabrielDirectorSSale−2.94K$15.77−$46.4K−3.2%89.5K after
Jun 3, 2026 (view filing)Jun 21 dayHilleman Jeryl LDirectorSSale−2.94K$15.77−$46.4K−17.5%13.9K after
Mar 5, 2026 (view filing)Mar 41 dayBrackmann ChristophChief Financial OfficerSSale−6.41K$13.31−$85.3K−3.4%182.8K after
Mar 5, 2026 (view filing)Mar 4-51 dayParavasthu MukundChief Operating OfficerSSale−48.6K$13.72−$667.1K−40.0%72.8K after2 lots
Mar 5, 2026 (view filing)Mar 41 dayLeupin NicolasFormer Chief Medical OfficerSSale−1.10K$13.31−$14.6K−1.1%103.0K after
Mar 5, 2026 (view filing)Mar 41 dayPuri Michal NathChief Human Resources OfficerSSale−1.10K$13.31−$14.6K−0.5%201.3K after
Mar 5, 2026 (view filing)Mar 41 dayLeonard Frank XChief Executive OfficerSSale−5.61K$13.31−$74.6K−1.1%493.8K after
Mar 5, 2026 (view filing)Mar 41 dayWeinberg UriChf Medical and Innovation OfrSSale−6.41K$13.31−$85.3K−2.3%267.2K after
Mar 5, 2026 (view filing)Mar 32 daysDoyle William FExecutive ChairmanSSale−71.9K$12.98−$933.1K−18.0%328.4K after2 lots
Mar 3, 2026 (view filing)Feb 27-Mar 24 daysParavasthu MukundChief Operating OfficerSSale−1.96K$13.62−$26.7K−2.5%76.3K after2 lots
Mar 3, 2026 (view filing)Feb 274 daysLeupin NicolasFormer Chief Medical OfficerSSale−1.03K$13.66−$14.1K−1.0%104.1K after
Mar 3, 2026 (view filing)Feb 274 daysPuri Michal NathChief Human Resources OfficerSSale−1.44K$13.66−$19.7K−0.9%162.3K after
Mar 3, 2026 (view filing)Feb 27-Mar 24 daysLeonard Frank XChief Executive OfficerSSale−17.0K$13.59−$230.5K−4.6%349.4K after2 lots
Mar 3, 2026 (view filing)Feb 27-Mar 24 daysWeinberg UriChf Medical and Innovation OfrSSale−10.7K$13.68−$146.9K−4.6%223.5K after2 lots
Sep 8, 2025 (view filing)Sep 53 daysCordova AshleyChief Executive OfficerPPurchase+81.5K$12.22+$996.5K+22.9%437.6K after
Jul 30, 2025 (view filing)Jul 291 dayBrackmann ChristophChief Financial OfficerPPurchase+20.0K$11.59+$231.8K+16.5%141.2K after3 lots
Jun 4, 2025 (view filing)Jun 31 dayStafford KristinDirectorSSale−999$17.28−$17.3K−24.6%3.05K after
Jun 4, 2025 (view filing)Jun 31 dayLeung GabrielDirectorSSale−999$17.31−$17.3K−1.2%81.2K after
Jun 4, 2025 (view filing)Jun 31 dayMadden Martin J.DirectorSSale−999$17.19−$17.2K−5.1%18.7K after
Jun 4, 2025 (view filing)Jun 31 dayScannell Timothy JDirectorSSale−999$17.32−$17.3K−14.2%6.02K after
Jun 4, 2025 (view filing)Jun 31 dayHilleman Jeryl LDirectorSSale−999$17.26−$17.2K−15.2%5.59K after
Jun 4, 2025 (view filing)Jun 31 dayOcean Allyson JDirectorSSale−999$17.29−$17.3K−24.6%3.05K after
Jun 4, 2025 (view filing)Jun 31 dayVernon W AnthonyDirectorSSale−999$17.35−$17.3K−0.6%167.9K after
Jun 4, 2025 (view filing)Jun 31 dayHung DavidDirectorSSale−999$17.30−$17.3K−7.6%12.2K after
Jun 4, 2025 (view filing)Jun 22 daysLeonard Frank XEVP, Pres., Novocure OncologySSale−30.2K$17.50−$528.4K−15.2%168.5K after3 lots10b5-1
May 5, 2025 (view filing)May 32 daysParavasthu MukundChief Operating OfficerSSale−592$17.91−$10.6K−0.7%83.6K after
Mar 4, 2025 (view filing)Mar 31 dayWeinberg UriChief Innovation OfficerSSale−268$18.92−$5.07K−0.2%166.2K after
Mar 4, 2025 (view filing)Mar 31 dayLeonard Frank XEVP, Pres., Novocure OncologySSale−2.53K$18.54−$46.9K−1.7%143.7K after
Mar 4, 2025 (view filing)Mar 31 dayCordova AshleyChief Executive OfficerSSale−2.05K$18.54−$38.1K−1.0%204.0K after
Mar 4, 2025 (view filing)Mar 31 dayParavasthu MukundChief Operating OfficerSSale−250$18.54−$4.63K−0.8%29.2K after
Mar 3, 2025 (view filing)Feb 283 daysWeinberg UriChief Innovation OfficerSSale−4.64K$18.75−$86.9K−2.7%166.5K afterAmended2 lots
Mar 3, 2025 (view filing)Feb 27-284 daysCordova AshleyChief Executive OfficerSSale−13.5K$19.72−$266.1K−6.1%206.1K afterAmended3 lots
Mar 3, 2025 (view filing)Feb 27-284 daysLeonard Frank XEVP, Pres., Novocure OncologySSale−15.0K$19.70−$296.2K−9.3%146.2K afterAmended3 lots
Mar 3, 2025 (view filing)Feb 274 daysPuri Michal NathChief Human Resources OfficerSSale−1.39K$20.02−$27.8K−1.3%108.7K afterAmended2 lots
Mar 3, 2025 (view filing)Feb 274 daysLeupin NicolasChief Medical OfficerSSale−991$20.02−$19.8K−1.9%50.1K afterAmended2 lots
Mar 3, 2025 (view filing)Feb 27-284 daysParavasthu MukundChief Operating OfficerSSale−2.01K$19.70−$39.7K−6.4%29.4K afterAmended3 lots
Jan 15, 2025 (view filing)Jan 114 daysLateParavasthu MukundChief Operating OfficerSSale−2.16K$26.81−$57.9K−6.4%31.4K after
Nov 6, 2024 (view filing)Nov 24 daysLateParavasthu MukundChief Operating OfficerSSale−44$16.69−$734.36−1.3%3.46K after
Nov 4, 2024 (view filing)Oct 314 daysPuri Michal NathChief Human Resources OfficerSSale−810$15.79−$12.8K−0.7%110.1K after
Nov 4, 2024 (view filing)Nov 13 daysLeonard Frank XEVP, Pres., Novocure OncologySSale−598$15.94−$9.53K−0.4%161.2K after
Nov 4, 2024 (view filing)Nov 13 daysParavasthu MukundChief Operating OfficerSSale−160$15.88−$2.54K−4.4%3.50K after
Aug 5, 2024 (view filing)Aug 23 daysCordova AshleyChief Financial OfficerSSale−688$20.14−$13.9K−0.3%219.2K after
Jun 6, 2024 (view filing)Jun 42 daysVernon W AnthonyDirectorSSale−964$23.89−$23.0K−0.6%164.8K after
Jun 6, 2024 (view filing)Jun 42 daysScannell Timothy JDirectorSSale−964$23.89−$23.0K−24.5%2.96K after